Success Stories: EB-2 NIW Approval for Scientist Advancing Pediatric Cancer Research
Client’s Testimonial:
“Thank you for the message. Yes, it was great working with you. The attorney was excellent so far. I am happy with the service provided.”
On August 21st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Student in the Field of Physics (Approval Notice).
General Field: Protein Science
Position at the Time of Case Filing: Scientist
Country of Origin: India
State of Residence at the Time of Filing: Tennessee
Approval Notice Date: August 21st, 2025
Processing Time: 5 months, 16 days (Premium Processing Requested)
Case Summary:
NAILG is proud to share another EB-2 NIW (National Interest Waiver) success, this time for a scientist from India specializing in protein science. The petition was filed on March 5, 2025, and, after a request for evidence issued on April 17, it was approved on August 21, 2025, with the help of premium processing.
Pioneering Research in Protein Science
The client’s work is centered on uncovering molecular mechanisms and signaling pathways in pediatric cancers. His goal is to identify therapeutic targets and develop targeted treatments that reduce healthcare burdens while improving survival outcomes. This line of research not only addresses a pressing medical challenge in the United States but also contributes to broader global health needs.
Accomplishments and Scholarly Recognition
- Publications: 13 peer-reviewed journal articles and 1 first-authored abstract in leading journals of biochemistry, protein science, and structural biology.
- Citations: His work has accrued 193 citations, with three papers ranking among the top 20% most cited in their respective years.
- Peer Reviews: Completed at least 12 reviews for respected journals in molecular biosciences and protein chemistry.
- Editorial Service: Invited to serve on an editorial board and as guest editor of a special issue, roles that reflect his standing in the scientific community.
- Funding: His research has benefited from national and institutional support, including projects tied to cancer biology and drug development.
Why USCIS Approved the Petition
In our legal strategy, NAILG demonstrated that:
- His research has substantial merit and national importance, tackling one of the leading causes of childhood mortality in the U.S.
- He is well-positioned to advance the endeavor, evidenced by his publication record, citation impact, peer review service, and editorial leadership.
- On balance, granting a waiver of the labor certification requirement is clearly beneficial to the United States, as his expertise directly supports progress in cancer treatment and biomedical innovation.
With this approval, the client is poised to continue driving forward protein science innovations that can transform the treatment of pediatric cancers. At NAILG, we are honored to have supported his journey and look forward to his future contributions to public health and biomedical research in the United States.